Thursday, 21 August 2014

Cancer Immunotherapy a late sucess story

Forged out of the knowledge from decades of cancer and immunology research, Immunotherapy is emerging as an effective therapy against cancer. Saman Maleki profiles the recent development of a new immunotherapy drug, Ipilimumab, which disables one of cancer's defences against immune cell attack.

Cancer Immunotherapy a late sucess story. Published in The Londoner (August 21th, page 10).

Saman Maleki holds a PhD in Cancer Immunology from Western University.

Part of the monthly series "Promise and Progress in Research" co-ordinated by the Canadian Cancer Society Volunteer Research Information Outreach Team (RIOT), London and published in The Londoner.

No comments:

Post a Comment